Skip to content

Clinical trials

Completed Phase 3 Autoimmune Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Phase 3 Status: Completed Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20063
20072
20083
20091
20103
20115
20121
20133
20151
20161
20181
20211
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Human Genome Sciences Inc., a GSK Company5
Eli Lilly and Company2
Human Genome Sciences Inc.2
Immunovant Sciences GmbH2
National Institute of Mental Health (NIMH)2
Seoul National University Hospital2
Allergan1
Amgen1
Anthera Pharmaceuticals1
Baxalta now part of Shire1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases33
Lupus Erythematosus, Systemic11
Arthritis, Rheumatoid6
Immune System Diseases6
Connective Tissue Diseases3
Joint Diseases3
Nervous System Diseases3
Rheumatic Diseases3
Arthritis2
Autoimmune Diseases of the Nervous System2

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.